← Evidence map

ReviewImmunotherapy advances2025

Insights from the bottom-up development of LGR5-targeting immunotherapeutics.

Nico Mueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40405910